In January 2010, the Free Cancer Foundation established an endowment of $500,000, the income from which is restricted to promoting research related to the recovery from cancer. All gains, whether unrealized or realized are available for distribution. Through 2010 the market value of endowment's investment portfolio increased to $520,000. Accordingly, at the year end $20,000 was credited to a temporarily restricted expendable fund. During 2011, the market value of the portfolio decreased to $480,000 and the foundation spend $12,000 on qualifying projects. Owing to these events and transactions, what could be the reported net asset balance of the subsequent categories during 2011: permanent restricted, temporarily restricted, unrestricted